Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas

Journal of Clinical Oncology

Volumn 17, Issue 4, 1999, Pages 1244-1253

  Cheson, Bruce D ^a   Horning, Sandra J ^a   Coiffier, Bertrand ^a   Shipp, Margaret A ^a   Fisher, Richard I ^a   Connors, Joseph M ^a   Lister, T Andrew ^a   Vose, Julie ^a   Grillo López, Antonio ^a   Hagenbeek, Anton ^a   Cabanillas, Fernando ^a   Klippensten, Donald ^a   Hiddemann, Wolfgang ^a   Castellino, Ronald ^a   Harris, Nancy L ^a   Armitage, James O ^a   Carter, William ^a   Hoppe, Richard ^a   Canellos, George P ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESEARCH; DRUG RESPONSE; FLOW CYTOMETRY; HUMAN; INTERNATIONAL COOPERATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION;

EID: 0042449063     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.4.1244     Document Type: Article

References (51)

1. Cheson BD, Bennett JM, Rai KR, et al: Guidelines for clinical protocols for chronic lymphocytic leukemia: Report of the NCI-sponsored Working Group. Am J Hematol 29:152-163, 1988
2. Cheson BD, Bennett JM, Grever M, et al: National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87:4990-4997, 1996
3. Cheson BD, Cassileth PA, Head DR, et al: Report of the NCI-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813-819, 1990
4. Lister TA, Crowther D, Sutcliffe SB, et al: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds Meeting. J Clin Oncol 7:1630-1636, 1989
5. Therasse P, Eisenhauer E, Wanders J, et al: Evaluation of response to treatment in solid tumors. Can the methodology be harmonized and simplified? Ann Oncol 2:25, 1998 (suppl) (abstr)
6. Dixon DO, McLaughlin P, Hagemeister FB, et al: Reporting outcomes in Hodgkin's disease and lymphoma. J Clin Oncol 5:1670-1672, 1987
7. Anderson JR, Propert KJ, Harrington DP: Guidelines for reporting outcomes of lymphoma trials. J Clin Oncol 6:559-560, 1988 (letter)
8. Horning S, Cheson B, Peterson B, et al: Response criteria (RC) and quality assurance (QA) of responses in the evaluation of new therapies for patients with low-grade lymphoma (LGNHL). Proc Am Soc Clin Oncol 16:18a, 1997 (abstr 61)
9. Grillo-López AJ, Horning S, Cheson B, et al: Development of response criteria (RC) for low-grade or follicular lymphomas (LG/ FNHL) and application in a 166 patient study. Exper Hematol 25:732, 1997 (abstr 17)
10. Pappa VI, Hussain HK, Raeznek RH, et al: Role of image-guided core-needle biopsy in the management of patients with lymphoma. J Clin Oncol 14:2427-2430, 1996
11. Ben-Yehuda D, Polliack A, Okon E, et al: Image-guided core-needle biopsy in malignant lymphoma: Experience with 100 patients that suggests the technique is reliable. J Clin Oncol 14:2431-2434, 1996
12. Coller BS, Chabner BA, Gralnick HR: Frequencies and patterns of bone marrow involvement in non-Hodgkin's lymphomas: Observations on the value of bilateral biopsies. Am J Hematol 3:105-119, 1977
13. Bitran JD, Golomb HM, Ultmann JE, et al: Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: Results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer 42:88-95, 1978
14. Dorfman RE, Alpern MB, Gross BH, et al: Upper abdominal lymph nodes: Criteria for normal size determined with CT. Radiology 180:319-322, 1991
15. Einstein DM, Singer AA, Chilcote WA, et al: Abdominal lymphadenopathy: Spectrum of CT findings. Radiographics 11:457-472, 1991
16. Glazer GM, Gross BH, Quint LE, et al: Normal mediastinal lymph nodes: Number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144:261-265, 1985
17. Hopper KD, Kasales CJ, Van Slyke MA, et al: Analysis of interobserver and intraobserver variability in CT tumor measurements. AJR Am J Roentgenol 187:851-854, 1996
18. Kiyono K, Sone S, Sakai F, et al: The number and size of normal mediastinal lymph nodes: A postmortem study. AJR Am J Roentgenol 150:771-776, 1988
19. Steinkamp HJ, Hosten N, Richter C, et al: Enlarged cervical lymph nodes at helical CT. Radiology 191:795-798, 1994
20. van den Brekel MWM, Castelijns JA, Snow GB: Detection of lymph node metastases in the neck: Radiologic criteria. Radiology 192:617-617, 1994
21. Genereux GP, Howie JL: Normal mediastinal lymph node size and number: CT and anatomic study. AJR Am J Roentgenol 142:1095-1100, 1984
22. Lewis E, Bernardino ME, Salvador PG, et al: Post-therapy CT-detected mass in lymphoma patients: Is it viable tissue? J Comput Assist Tomogr 6:792-795, 1982
23. Grillo-López AJ, McLaughlin P, Cheson BD, et al: First report on the application of the new response criteria (RC) proposed for NHL: The Rituximab pivotal trial. Proc Am Soc Clin Oncol (in press)
24. Grillo-López AJ, Cheson B, Horning S, et al: Response criteria (RC) for NHL: Importance of "normal" lymph node (LN) size and correlations with response. Blood 92:412a, 1998 (abstr 1701) (suppl 1)
25. Fuks JZ, Aisner J, Wiernik PH: Restaging laparotomy in the management of the non-Hodgkin lymphomas. Med Pediatr Oncol 10:429-438, 1982
26. Stewart FM, Williamson BR, Innes DJ, et al: Residual tumor masses following treatment for advanced histiocytic lymphoma. Cancer 55:620-623, 1985
27. Surbone A, Longo DL, DeVita VT Jr, et al: Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: Significance and management. J Clin Oncol 6:1832-1837, 1988
28. Longo DL, DeVita VT Jr, Duffey PL, et al: Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial. J Clin Oncol 9:25-38, 1991
29. Waits TM, Greco FA, Greer JP, et al: Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy. J Clin Oncoi 11:943-949, 1993
30. Meyer RM, Quirt IC, Skillings JR, et al: Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma. N Engl J Med 329:1770-1776, 1993
31. Zuckerman KS, LoBuglio AF, Reeves JA: Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with a high-dose doxorubicin-containing regimen. J Clin Oncol 8:248-256, 1990
32. Zuckerman KS, Case DC Jr, Gams RA, et al: Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen. Blood 82:3564-3573, 1993
33. Coiffier B, Gisselbrecht C, Herbrecht R, et al: LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018-1026, 1989
34. Chopra R, Goldstone AH, Pearce R, et al: Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 10:1690-1695, 1992
35. Strijk SP, Boetes C, Bogman MJJT, et al: The spleen in non-Hodgkin lymphoma: Diagnostic value of computed tomography. Acta Radiol 28:139-144, 1987
36. Breiman RS, Beck JW, Korobkin M, et al: Volume determinations using computed tomography. AJR Am J Roentgenol 138:329-333, 1982
37. Shipp MA, Ambinder RF, Appelbaum FR, et al: NCCN preliminary non-Hodgkin's lymphoma practice guidelines. Oncology (Huntingt) 11:281-346, 1997
38. Weeks JC, Yeap BY, Canellos GP, et al: Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol 9:1196-1203, 1991
39. Vose JM, Bierman PJ, Anderson JR, et al: Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 14:2473-2479, 1996
40. Longo DL, Schilsky RL, Blei L, et al: Gallium-67 scanning: Limited usefulness in staging patients with non-Hodgkin's lymphoma. Am J Med 68:695-700, 1980
41. Hill M, Cunningham D, MacVicar D, et al: Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J Clin Oncol 11:2273-2278, 1993
42. Israel O, Front D, Lam M, et al: Gallium 67 imaging in monitoring lymphoma response to treatment. Cancer 61:2439-2443, 1988
43. Kaplan WD, Jochelson MS, Herman TS, et al: Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 8:1966-1970, 1990
44. Janicek M, Kaplan W, Neuberg D, et al: Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol 15:1631-1637, 1997
45. Even-Sapir E, Bar-Shalom R, Israel O, et al: Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol 13:942-946, 1995
46. Römer W, Hahauske A-R, Zieger S, et al: Positron-emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose. Blood 91:4464-4411, 1998
47. Devizzi L, Maffiolo L, Bonfante V, et al: Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease. Ann Oncol 8:53-56, 1997
48. Hoane BR, Shields AF, Porter BA, et al: Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood 78:728-738, 1991
49. Altehoefer C, Blum U, Bathmann J, et al: Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintography for detection of bone marrow involvement in patients with malignant lymphoma. J Clin Oncol 15:1754-1760, 1997
50. Moog F, Bangerter M, Kotzerke J, et al: 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Blood 16:603-609, 1998
51. Carr R, Barrington SF, Madan B, et al: Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91:3340-3346, 1998